Cite
HARVARD Citation
Levy, M. et al. (n.d.). ATR inhibitor camonsertib (RP-3500) suppresses early-stage erythroblasts by mediating ferroptosis. European journal of cancer. pp. S100-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Levy, M. et al. (n.d.). ATR inhibitor camonsertib (RP-3500) suppresses early-stage erythroblasts by mediating ferroptosis. European journal of cancer. pp. S100-. [Online].